Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma

被引：25
|
作者：
Rasi, G [1 ]
Terzoli, E
Izzo, F
Pierimarchi, P
Ranuzzi, M
Sinibaldi-Vallebona, P
Tuthill, C
Garaci, E
机构：
[1] CNR, Ist Med Sperimentale, I-00137 Rome, Italy
[2] Univ Rome Tor Vergata, Rome, Italy
[3] Ist Regina Elena, I-00161 Rome, Italy
[4] SciClone Pharmaceut Inc, San Mateo, CA USA
来源：
MELANOMA RESEARCH | 2000年 / 10卷 / 02期
关键词：
advanced melanoma; combination treatment; DTIC; interferon; thymosin-alpha; 1;
D O I：
10.1097/00008390-200010020-00012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：189 / 192
页数：4
相关论文
共 50 条
  • [11] Type 1 diabetes mellitus caused by treatment with low-dose interferon-α in a melanoma patient
    Sossau, Daniel
    Kofler, Lukas
    Eigentler, Thomas
    MELANOMA RESEARCH, 2017, 27 (05) : 516 - 518
  • [12] Combination thymosin-α1 and interferon-α2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey
    Saruc, M
    Yuceyar, H
    Kucukmetin, N
    Demir, MA
    Kandiloglu, AR
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 798 - 802
  • [13] Thymosin-α 1 plus interferon-α for naive patients with chronic hepatitis C:: results of a randomized controlled pilot trial
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Felline, F
    Loggi, E
    D'Errico, A
    Spinosa, M
    Lorenzini, S
    Biselli, M
    Bernardi, M
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (01) : 69 - 73
  • [14] Combined interferon-α and interleukin 2 as adjuvant treatment for melanoma
    Dummer, R
    Hauschild, A
    Henseler, T
    Burg, G
    LANCET, 1998, 352 (9131): : 908 - 909
  • [15] COMBINED THERAPY WITH DACARBAZINE, VINDESINE AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC MELANOMA
    MANSATKRZYZANOWSKA, E
    DRENO, B
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1994, 121 (12): : 884 - 887
  • [16] Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
    Maio, Michele
    Mackiewicz, Andrzej
    Testori, Alessandro
    Trefzer, Uwe
    Ferraresi, Virginia
    Jassem, Jacek
    Garbe, Claus
    Lesimple, Thierry
    Guillot, Bernard
    Gascon, Pere
    Gilde, Katalin
    Camerini, Roberto
    Cognetti, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1780 - 1787
  • [17] Low dose interferon-α plus tamoxifen in the treatment of recurred melanoma patients after adjuvant therapy:: The experience of Melanoma Cooperative Group of Naples.
    Ascierto, PA
    Daponte, A
    Parasole, R
    Caracò, C
    Melucci, MT
    Palmieri, G
    Comella, G
    Mozzillo, N
    Castello, G
    ANNALS OF ONCOLOGY, 2000, 11 : 129 - 130
  • [18] Fotermustine and dacarbazine plus recombinant interferon alpha2a in the treatment of advanced melanoma
    Comella, P
    Daponte, A
    Casaretti, R
    Ionna, F
    Fiore, F
    Presutti, F
    Frasci, G
    Caponigro, F
    Gravina, A
    Parziale, AP
    Mozzillo, N
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1326 - 1329
  • [19] In vitro effect of thymosin-α1 and interferon-α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
    Andreone, P
    Cursaro, C
    Gramenzi, A
    Margotti, M
    Ferri, E
    Talarico, S
    Biselli, M
    Felline, F
    Tuthill, C
    Martins, E
    Gasbarrini, G
    Bernardi, M
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (03) : 194 - 201
  • [20] Long-term outcome of treatment with dacarbazine, cisplatin, interferon-α and intravenous high dose interleukin-2 in poor risk melanoma patients
    Proebstle, TM
    Fuchs, T
    Scheibenbogen, C
    Sterry, W
    Keilholz, U
    MELANOMA RESEARCH, 1998, 8 (06) : 557 - 563
12345